Federal Register notice: FDA makes available two draft device-specific guidance documents for the Safety and Performance Based Pathway one on denture...
FDA Review posts the Federal Register notices for the week ending 8/27/2021.
FDA Review posts product approval summaries for the week ending 8/27/2021.
Roche withdraws its accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for treating adults with unresectable locally a...
Federal Register notice: FDA withdraws the approval of a Breckenridge Pharmaceutical ANDA for solifenacin succinate tablets (5mg and 10mg) after the c...
Federal Register notice: CDER announces that 10/18 is the effective date that it will begin rejecting submissions that fail either Electronic Common T...
FDA posts a draft guidance entitled Facet Screw Systems Performance Criteria for Safety and Performance Based Pathway.